Diagnosis and treatment of insulin dependent diabetes mellitus
CA 2029861 C · Owner: Elias, Dana · Inventors: Elias, Dana; Markovits, Doron; Cohen, Irun R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A 65 KD heat shock protein, proteins, cross-reactive therewith antibodies thereto or T cells, specific thereto can be used for detecting in humans the existence of, a tendency to develop, or the initiation of a process leading to insulin dependent diabetes mellitus. Antibodies to hsp65 can be used to detect the hsp65 molecule in blood or urine. The hsp65 molecule of any species, or any other substance immunologically cross-reactive therewith, when administered with a tolerogenic carrier, can be used for the prevention or treatment of IDDM prior to development of clinical symptoms thereof. T cells, active fragments thereof or the receptor peptide thereof can also be used for prevention or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 14, 1990 and granted January 16, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 14, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 14, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.